See more : PVH Corp. (0KEQ.L) Income Statement Analysis – Financial Results
Complete financial analysis of Ray Co., Ltd. (228670.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ray Co., Ltd., a leading company in the Medical – Specialties industry within the Healthcare sector.
- Jazan Energy and Development Company (6090.SR) Income Statement Analysis – Financial Results
- Arakawa Chemical Industries, Ltd. (4968.T) Income Statement Analysis – Financial Results
- The Bank of East Asia, Limited (BKEAY) Income Statement Analysis – Financial Results
- Hexagon Composites ASA (HEX.OL) Income Statement Analysis – Financial Results
- American Creek Resources Ltd. (ACKRF) Income Statement Analysis – Financial Results
Ray Co., Ltd. (228670.KQ)
About Ray Co., Ltd.
RAY Co., Ltd. provides x-ray diagnostic equipment in the dental industry. The company offers RAYSACN Series, RAYios, RAYFace, RAYDENT Microscan, RIO Series, RAYDENT designer and tray, RAYSmiler, RAYDENT Studio, and RAYDENT Mill 4X and 5X, as well as consumables. RAY Co., Ltd. was incorporated in 2004 and is headquartered in Seongnam-si, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 145.88B | 129.00B | 90.34B | 55.20B | 73.11B | 51.53B | 32.93B |
| Cost of Revenue | 80.79B | 69.88B | 60.88B | 30.75B | 39.71B | 29.28B | 18.22B |
| Gross Profit | 65.09B | 59.12B | 29.46B | 24.46B | 33.40B | 22.26B | 14.71B |
| Gross Profit Ratio | 44.62% | 45.83% | 32.61% | 44.31% | 45.69% | 43.19% | 44.67% |
| Research & Development | 6.99B | 6.16B | 4.70B | 3.91B | 3.22B | 2.84B | 2.01B |
| General & Administrative | 6.64B | 3.99B | 1.81B | 1.55B | 419.65M | 0.00 | 0.00 |
| Selling & Marketing | 12.56B | 8.52B | 4.51B | 3.01B | 3.71B | 0.00 | 0.00 |
| SG&A | 52.05B | 36.75B | 21.37B | 15.97B | 17.32B | 13.37B | 10.75B |
| Other Expenses | 0.00 | -61.65M | -3.66M | 324.88M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 59.03B | 42.91B | 26.07B | 19.88B | 20.54B | 16.21B | 12.76B |
| Cost & Expenses | 139.83B | 112.79B | 86.95B | 50.62B | 60.25B | 45.49B | 30.98B |
| Interest Income | 459.40M | 631.17M | 839.60M | 202.53M | 125.83M | 10.54M | 5.24M |
| Interest Expense | 3.23B | 2.73B | 1.32B | 230.55M | 187.27M | 132.75M | 134.28M |
| Depreciation & Amortization | 8.43B | 5.93B | 5.45B | 4.38B | 2.38B | 1.02B | 779.52M |
| EBITDA | 7.62B | 22.13B | 9.09B | 8.96B | 15.24B | 7.36B | 1.91B |
| EBITDA Ratio | 5.23% | 17.16% | 9.78% | 16.23% | 20.84% | 13.71% | 8.28% |
| Operating Income | 6.12B | 16.21B | 3.39B | 4.58B | 12.86B | 6.05B | 1.95B |
| Operating Income Ratio | 4.19% | 12.56% | 3.75% | 8.30% | 17.59% | 11.74% | 5.91% |
| Total Other Income/Expenses | -10.35B | -4.74B | -6.15B | 2.03B | -1.05B | 165.62M | -949.81M |
| Income Before Tax | -4.23B | 10.59B | -2.72B | 8.79B | 13.28B | 6.21B | 996.17M |
| Income Before Tax Ratio | -2.90% | 8.21% | -3.01% | 15.92% | 18.16% | 12.06% | 3.03% |
| Income Tax Expense | -1.19B | 3.51B | -2.82B | 961.12M | 1.72B | 962.01M | -158.03M |
| Net Income | -2.15B | 7.96B | -12.76M | 7.90B | 11.56B | 5.25B | 1.15B |
| Net Income Ratio | -1.47% | 6.17% | -0.01% | 14.32% | 15.81% | 10.19% | 3.51% |
| EPS | -140.25 | 540.97 | -0.91 | 593.97 | 957.31 | 394.65 | 86.74 |
| EPS Diluted | -140.25 | 539.08 | -0.91 | 593.97 | 957.31 | 394.65 | 86.74 |
| Weighted Avg Shares Out | 15.30M | 14.71M | 13.95M | 13.31M | 12.07M | 13.31M | 13.31M |
| Weighted Avg Shares Out (Dil) | 15.30M | 14.76M | 13.95M | 13.31M | 12.07M | 13.31M | 13.31M |
Source: https://incomestatements.info
Category: Stock Reports